Diagnostic value of HMB-45 and anti-Melan A staining of sentinel lymph nodes with isolated positive cells

Modern Pathology

Volumn 15, Issue 12, 2002, Pages 1288-1293

  Mahmood, Muhammad N ^a   Lee, Min W ^a   Linden, Michael D ^a   Nathanson, S D ^a   Hornyak, Thomas J ^a   Zarbo, Richard J ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Anti Melan A; HMB 45; Melanophages; Metastatic melanoma; Sentinel lymph node

Indexed keywords

BIOTIN; MELAN A; MELAN A ANTIBODY; MONOCLONAL ANTIBODY HMB 45; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPIGMENTATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPHATIC DRAINAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; RELIABILITY; SENTINEL LYMPH NODE; SKIN BIOPSY; STAINING;

ANTIGENS, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM PROTEINS; PREDICTIVE VALUE OF TESTS; SENTINEL LYMPH NODE BIOPSY; SKIN;

EID: 0036901512     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000037313.33138.DF     Document Type: Article

References (32)

1. Baisden BL, Askin FB, Lange JR, Westra WH. HMB-45 immunohistochemical staining of sentinel lymph nodes. A specific method for enhancing detection of micrometastases in patients with melanoma. Am J Surg Pathol 2000;24:1140-6.
2. Robert ME, Wen DR, Cochran AJ. Pathological evaluation of the regional lymph nodes in malignant melanoma. Semin Diagn Pathol 1993;10:102-15.
3. Balch CM, Murad TM, Soong SJ. Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer 1975;35:666-76.
4. Lee YTN. Diagnosis, treatment and prognosis of early melanoma. The importance of depth of microinvasion. Ann Surg 1980;191:87-97.
5. Morton DL, Wen DR, Wong JH. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
6. Reintgen D, Cruse CW, Wells K. The orderly progression of melanoma nodal metastasis. Ann Surg 1994;220:759-67.
7. McMaster KM, Tuttle TM, Carlson DJ, Brown CM. Sentinel lymph node biopsy for breast cancer a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000;18:2560-6.
8. Cochran AJ, Wen DR, Morton DL. Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistochemical study. Am J Surg Pathol 1988;12:612-8.
9. Cochran AJ, Wen DR, Herschman HR. Occult melanoma in lymph nodes detected by antiserum to S-100 protein. Int J Cancer 1984;34:159-63.
10. Gibbs JF, Huang PP, Zhang PJ, Kraybill WG, Cheney R. Accuracy of pathologic techniques for the diagnosis of metastatic melanoma in sentinel lymph nodes. Ann Surg Oncol 1999;6:699-704.
11. Schaumburg-Lever G. New applications of electron microscopy techniques in dermatopathology. J Cutan Pathol 1995; 22:483-7.
12. Gown AM, Vogel AM, Hoak D, Gough F, Mcnutt MA. Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. Am J Pathol 1986;123: 195-203.
13. Colombari R, Bonetti F, Zamboni G. Distribution of melanoma specific antibody(HMB-45) in benign and malignant melanocytic tumors. Virchows Arch A Pathol Anat 1988;413: 17-24.
14. Holbrook KA, Underwood RA, Vogel AM. The appearance, density and distribution of melanocytes in human embryonic and fetal skin revealed by anti-melanoma antibody HMB-45. Anal Embryol 1989;180:443-5.
15. Bonetti F, Pea M, Martignoni G. False positive immunostaining of normal epithelia and carcinomas with ascites fluid preparations of anti-melanoma monoclonal antibody HMB-45. Am J Clin Pathol 1991;95:454-9.
16. Achilles E, Schroder S. Positive cytokeratin results in malignant melanoma. Pitfall in differential immunohistological diagnosis of occult neoplasms. Pathologe 1994;15:235-41.
17. Messina JL, Glass F, Cruse CW, Berman C, Ku NK, Reintgen DS. Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg Pathol 1999;23:686-90.
18. Scheffer E, Meijer CJLM, Van Volten WA. Dermatopathic lymphadenopathy and lymph node involvement in mycosis fungoides. Cancer 1980;45:137-48.
19. Hatta N, Takata M, Takehara K, Ohara K. Polymerase chain reaction and immunohistochemistry frequently detect occult melanoma cells in regional lymph nodes of melanoma patients. J Clin Pathol 1998;51:597-601.
20. Coulie PG, Brichard V, Van Pal A, Wolfel T, Schneider J, Traversari C. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994;180:35-42.
21. Fetsch PA, Cormier J, Hijazi YM. Immunocytochemical detection of MART-1 in fresh and paraffin embedded malignant melanomas. J Immunother 1997;20:60-4.
22. Kawakami Y, Battles JK, Kobayashi T, Ennis W, Wang X, Tupesis JP, et al. Production of recombinant MART-1 proteins and specific anti-MART-1 polyclonal and monoclonal antibodies: Use in the characterization of the human melanoma antigen MART-1. J Immunol Methods 1997;202:13-25.
23. Sarantou T, Chi DDJ, Garrison DA, Conrad AJ, Schmid P, Morton DL. Melanoma-associated antigens as messenger RNA detection markers for melanoma. Cancer Res 1997;57: 1371-6.
24. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Sakaguchi K, Apella E. Identification of a human melanoma antigen recognized by tumor infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci U S A 1994;91:6458-62.
25. Jungbluth A, Bausam K, Gerald W, Stockert E, Coplan K, Iversen K. A103: An anti-Melan-A monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Am J Surg Pathol 1998;22:595-602.
26. Chen YT, Stockert E, Jungbluth A, Tsang S, Coplan KA, Scanlan MJ. Serological analysis of Melan-A, a melanocytespecific protein homogeneously expressed in human melanomas. Proc Natl Acad Sci U S A 1996;93:5915-9.
27. Gaffey MJ, Mills SE, Askin FB, Ross GW, Sale GE, Kulander BG, et al. Clear cell tumor of the lung. A clinicopathologic, immunohistochemical, and ultrastructural study of eight cases, Am J Surg Pathol 1990;14:248-59.
28. Van Duinen SG, Ruiter DJ, Scheffer E. A staining procedure for melanin in semi thin and ultra thin epoxy sections. Histopathology 1986;7:35-48.
29. Thompson W, Mackie RM. Comparison of five antimelanoma antibodies for identification of melanocytic cells on tissue sections in routine dermatopathology. J Am Acad Dermatol 1989;21:1280-4.
30. Fernando SSE, Johnson S, Bate J. Immunohistochemical analysis of cutaneous malignant melanoma: Comparison of S-100 protein, HMB-45 monoclonal antibody and NK/C3 monoclonal antibody. Pathology 1994;26:16-9.
31. Kawakami Y, Bang N, Wang X, Rosenberg SA. Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T-lymphocytes from 123 patients with melanoma. J Immunother 2000;23:17-27.
32. Vijayasaradhi S, Xu Y, Bouchard B, Houghton AN. Intracellular sorting and targeting of melanosomal membrane proteins: Identification of signals for sorting of the human locus protein gp 75. J Cell Biol 1995;130:807-20.